Experience with prothrombin complex for the emergent reversal of anticoagulation in rural geriatric trauma patients

Surgery (United States)

Volumn 152, Issue 4, 2012, Pages 722-728

  Quick, Jacob A ^a   Bartels, Ashley N ^a   Coughenour, Jeffrey P ^a   Barnes, Stephen L ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; GERIATRIC PATIENT; HOSPITALIZATION; HUMAN; INJURY SCALE; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; HUMANS; INTENSIVE CARE; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MIDDLE AGED; PLASMA; RETROSPECTIVE STUDIES; RURAL POPULATION; TRAUMA CENTERS; WARFARIN; WOUNDS AND INJURIES;

EID: 84867084516     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.07.024     Document Type: Article

References (18)

1. L. Dossett, J. Riesel, M. Griffin, and B. Cotton Prevalence and implications of preinjury warfarin use Arch Surg 146 2011 565 570
2. C. Chong, T. Lew, P. Kuperan, J. Tan, L. Tan, and T. Kwek Rapid reversal of coagulopathy in warfarin-related ICH with prothrombin concentrates Anaesth Intensive Care 38 2010 474 480
3. F.A. Ivascu, G.A. Howells, F.S. Junn, H.A. Bair, P.J. Bendick, and R.J. Janczyk Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality J Trauma 59 2005 1131 1137
4. G. Li, S. Rachmale, M. Kojicic, K. Shahjehan, M. Malinchoc, and D. Kor Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients Transfusion 51 2011 338 343
5. De Castro GP, Bochicchio GV, Driscoll IR, Stein DM, Bochicchio KM, Zhu S, et al. Fresh frozen plasma transfusion is an independent risk factor for bacteremia in critically ill traumatic brain injury patients. Presented at the 31st Annual Meeting of the Surgical Infection Society, Palm Beach, FL, May 11-14, 2011 [abstr].
6. B. Nascimento, J. Callum, G. Rubenfeld, J.B. Rezende Neto, Y. Lin, and S. Rizoli Clinical review: Fresh frozen plasma in massive bleedings - more questions than answers Crit Care 14 2010 202
7. G. Dickneite Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation Thrombosis Res 119 2007 643 651
8. Baxter Healthcare Corporation. Bebulin VH [package insert]. Deerfield (IL): 2001.
9. S. Romagnoli, S. Bevilacqua, S. Gelsomino, S. Pradella, L. Ghilli, and C. Rostagno Small-dose recombinant activated factor VII (NovoSeven®) in Cardiac Surgery Anesth Analg 102 2006 1320 1326
10. B. Sorensen, D.R. Spahn, P. Innerhofer, M. Spannagl, and R. Rossaint Clinical review: prothrombin complex concentrates - evaluation of safety and thrombogenicity Crit Care 15 2011 201
11. F. Dentali, C. Marchesi, M. Pierfranceschi, M. Crowther, D. Garcia, and E. Hylek Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists Thromb Haemost 106 2011 429 438
12. S.J. Stanworth The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy Hematology Am Soc Hematol Educ Program 2007 179 186
13. J.H. Levy Perioperative hemostatic management of patients treated with vitamin K antagonists Anesthesiology 109 2008 918 926
14. E. Bershad, and J. Suarez Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature Neurocrit Care 12 2010 403 413
15. M. Kohler Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates Thromb Haemost 80 1998 399 402
16. F.E. Preston Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate: efficacy and safety in 42 patients Br J Haematol 116 2002 619 624
17. D.M. Stein, R.P. Dutton, M.E. Kramer, and T.M. Scalea Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma J Trauma 66 2009 63 72
18. M. Yasaka Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation Thromb Res 115 2005 455 459